British Journal of Cancer publishes first in-depth epidemiological characterisation of Neuroendocrine Tumours in the UK.
British Journal of Cancer publishes NET Patient Foundation’s research into impact of neuroendocrine morphology on cancer outcome and stage at diagnosis NET Patient Foundation in collaboration with Public Health England have undertaken the first in-depth epidemiological characterisation of Neuroendocrine Tumours in the UK to identify areas of unmet need with an aim to inform service improvement.
Recent News
Neuroendocrine Cancer Headlining the News
OCTOBER 2024 19/10//2024 'Doctors put my symptoms down to allergy - now I've got incurable cancer' It took four years for a cancer sufferer to get treatment for his very rare disease and by the time he did it had become incurable and inoperable. Saying he was going to...
PERT Update
As some of you may be aware, we are working with fellow charities and patient organisations to ‘lobby’ and work with the government and other stakeholders to better address PERT shortages. Our working group of charities and patient organisations meets monthly, and...
Fair Market Value for Charities in Partnership Work
Charities and patient organisations, like Neuroendocrine Cancer UK, alongside individual patients, play a crucial role in optimising equitable patient care: driving forward, facilitating and supporting, access to expert care, research and innovation. We are often the...